Leong Justin's Form 4 filing
Resmed Inc (RMD) · filed Nov 25, 2024
- Accession no.
- 0001127602-24-027960
- Filed
- Nov 25, 2024
- Trade date
- Nov 22, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $1.50M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leong JustinCIK 0001825782 | Officer (Chief Product Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | ReMed Common Stock | SSaleDisposed | −6,160 | $243.09F1 | −$1,497,434.4 | 21,718 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $243.00 - $243.315. The price reported above reflects the weighted average sale price.
Referenced by the price of 1 transaction in Table I.